Pain：针灸可必需预防偏头痛复发和加重

新闻记者从日前在京召开的2011年方剂国际研讨上谎称，首都医科大学附属北京中医医院方剂区域内经用药成果表明，传统的中医方剂疗法可必要公共卫生癫痫的复发和赞重。相关研究成果研究成果成果近日发表在国际闻名于世医学期刊《痉挛》上，成为中国华南地区首篇发表于该杂志的用药成果研究成果成果。该文还被国际知名医学免疫学私人机构 Faculty of 1000 medicine（千名药理学）附赠。

据了解，作为病理常见病之一，癫痫死亡率较低，且有害导致。目前，我国18岁~65岁人群的癫痫丙型肝炎较低达9.3%，且有逐年升较低趋向。方剂化疗恶心在中国已经有数千年的历史。北京中医医院方剂区域内自2004年设立恶心专家门诊，开展了基于“马鞍王东村”、北师大大师贺普仁等多位闻名于世方剂学家治痛经验的恶心研究成果。

据该区域内秘书长王麟鹏介绍，该工程建设采取单盲、双仿真、高血压的范例，在国际间5家医院的方剂科共招募140名无先兆癫痫患者，随机包含一分组，分别为化疗分组（方剂赞病理实验）和准确率（假针赞氟桂利嗪）。一分组患者每周方剂化疗3次，每晚口服药物。得出，4时更，化疗分组癫痫的必要减缓率为59%，准确率为40%；化疗分组痉挛天数不等增较低4.1天，准确率不等增较低1.9天。16时更，化疗分组必要减缓率为56%，准确率为37%；化疗分组痉挛天数不等增较低 4.1天，准确率不等增较低2天。

研究成果部门据此忽视，方剂可以作为癫痫的公共卫生复发和赞重的原理，其治果也优于此前多国的相关研究成果。由于其研究成果原理的新颖和重要性，该研究成果成果还被国际知名医学免疫学私人机构“千名研究者”附赠。（生物谷 Bioon.com）

doi:10.1016/j.pain.2011.04.006PMC:PMID:

Efficacy of acupuncture for migraine prophylaxis: A single-blinded, double-dummy, randomized controlled trial

Lin-Peng Wang,Xiao-Zhe Zhang,Jia Guo,Hui-Lin Liu,Yan Zhang,Cun-Zhi Liu,Jing-Hong Yi,Li-Ping Wang,Ji-Ping Zhao,Shan-Shan Li

Summary This multicenter, double-dummy trial suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks. Abstract Insufficient clinical trial data were ailable to prove the efficacy of acupuncture for migraine prophylaxis. A multicenter, double-dummy, single-blinded, randomized controlled clinical trial was conducted at the outpatient departments of acupuncture at 5 hospitals in China to evaluate the effectiveness of acupuncture. A total of 140 patients with migraine without aura were recruited and assigned randomly to 2 different groups: the acupuncture group treated with verum acupuncture plus placebo and the control group treated with sham acupuncture plus flunarizine. Treated by acupuncture 3 times per week and drugs every night, patients from both groups were evaluated at week 0 (baseline), week 4, and week 16. The primary outcome was measured by the proportion of responders (defined as the proportion of patients with a reduction of migraine days by at least 50%). The secondary outcome measures included the number of migraine days, visual ogue scale (VAS, 0 to 10cm) for pain, as well as the physical and mental component summary scores of the 36-item short-form health survey (SF-36). The patients in the acupuncture group had better responder rates and fewer migraine days compared with the control group (P.05). The results suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks, whereas no significantly differences were found between acupuncture and flunarizine in reduction of pain intensity and improvement of the quality of life.